Brand VerifiedGermany

CeramTec GmbH

CeramTec

CeramTec GmbH is the global gold standard in biomedical ceramics and a European pinnacle of precision industrial ceramics. Founded in 1903 in Plochingen, Baden-Württemberg, Germany, the company generates approximately €685 million (~$730 million) in annual revenue with ~3,500 employees across 18 highly modernized facilities on three continents. Privately held by BC Partners, CeramTec combines prec

GermanyEst. 1903~3,500~€685 million (~$730 million, FY2025)18 highly modernized production facilities concentrated in Germany (Plochingen, Lauf, etc.) with additional sites in the United States and AsiaPrivate (delisted; majority-owned by BC Partners private equity)Score 86

Business Nature

CeramTec operates as a capital and technology dual-intensive manufacturer highly dependent on precision machine tools and proprietary sintering patents. With 18 modernized production facilities across Germany, the USA, and Asia, the company combines century-old ceramic expertise with advanced manufacturing technologies including additive manufacturing 3D printing for complex ceramic components. The company serves over 10,000 different precision ceramic part specifications across medical, industrial, and electronics applications.

Core Business Areas

Medical Bioceramics — Core Business Global Gold Standard
• BIOLOX® ceramic-on-ceramic hip replacement systems world-leading biocompatibility
• High-density alumina and composite ceramic dental implant systems
• Ceramic knee and shoulder implant components
• Life-critical ceramic implant annual output exceeding 10 million units

Industrial & Electronic Ceramics — Core Business
• Piezoelectric ceramic ultrasonic sensors for industrial automation
• Fluid control ceramic seals and precision components
• Ceramic substrates for electronic and semiconductor applications
• Wear-resistant ceramic components for machinery and process equipment

Advanced Manufacturing Ceramics — Core Business
• ROCAR® silicon carbide SiC complex components via additive manufacturing 3D printing
• Custom-engineered ceramic solutions for specialized high-tech applications
• Over 10,000 different precision ceramic part specifications

Industry Rankings

9Top 10 Industrial Ceramic Substrates & Components Companies

Brand

Corporate Report

CeramTec GmbH is a Germany-based global leader in advanced structural and biomedical ceramics headquartered in Plochingen, Baden-Württemberg. Founded in 1903. Revenue ~€685 million (~$730 million), with ~3,500 employees across 18 modernized facilities worldwide. Privately held by BC Partners.

Business Overview

CeramTec stands as the global gold standard in biomedical ceramics and a European pinnacle of precision industrial ceramics. The company's BIOLOX® ceramic-on-ceramic hip replacement systems and high-density alumina composite dental implant systems have fundamentally redefined orthopedic surgery longevity expectations and biocompatibility limits. The company serves over 10,000 different precision ceramic part specifications. CeramTec is also a European leader in piezoelectric ultrasonic sensors for industrial automation, fluid control ceramic seals, and advanced additive manufacturing (3D printing) for complex silicon carbide (ROCAR®) components. In 2025, surging global demand for high-quality ceramic implants actually created a rare supply bottleneck, with certain dental implant product lines experiencing significant delivery delays — underscoring the company's technological irreplaceability in this specialized market segment.

Key Strengths

• BIOLOX® ceramic hip/dental implant systems: undisputed global gold standard in medical bioceramics
• 18 modernized production facilities on three continents
• Over 10,000 precision ceramic part specifications
• Pioneering additive manufacturing (3D printing) for complex SiC components (ROCAR®)
• Dominant European position in industrial automation ceramics and medical bioceramics

Challenges & Outlook

Severe supply capacity constraints for dental ceramic implants amid surging global demand require urgent production expansion. The company is investing significantly in expanding Swiss ceramic dental implant production lines. Private equity ownership under BC Partners creates a dual mandate of growth and profitability optimization. Long-term growth is anchored in expanding medical bioceramic production capacity and advancing additive manufacturing technologies for high-value industrial ceramic applications.

VerityRank Score

86/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Plochingen, Baden-Württemberg, Germany

Founded

1903

Employees

~3,500

Factories

18 highly modernized production facilities concentrated in Germany (Plochingen, Lauf, etc.) with additional sites in the United States and Asia

Listing

Private (delisted; majority-owned by BC Partners private equity)

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website

Back to Rankings